| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |